Количество 2
Количество 2
CVE-2026-56402
NanoClaw before 2.1.17 contains a privilege escalation vulnerability in the handleApprovalsResponse function that fails to verify responder role authorization. Attackers with a valid questionId can approve or reject privileged actions like package installation by submitting approval response payloads without proper role validation.
GHSA-mhq9-hcw8-22mj
NanoClaw before 2.1.17 contains a privilege escalation vulnerability in the handleApprovalsResponse function that fails to verify responder role authorization. Attackers with a valid questionId can approve or reject privileged actions like package installation by submitting approval response payloads without proper role validation.
Уязвимостей на страницу
Уязвимость | CVSS | EPSS | Опубликовано | |
|---|---|---|---|---|
 | CVE-2026-56402 NanoClaw before 2.1.17 contains a privilege escalation vulnerability in the handleApprovalsResponse function that fails to verify responder role authorization. Attackers with a valid questionId can approve or reject privileged actions like package installation by submitting approval response payloads without proper role validation. | CVSS3: 6.5 | 0% Низкий | 3 месяца назад |
| GHSA-mhq9-hcw8-22mj NanoClaw before 2.1.17 contains a privilege escalation vulnerability in the handleApprovalsResponse function that fails to verify responder role authorization. Attackers with a valid questionId can approve or reject privileged actions like package installation by submitting approval response payloads without proper role validation. | CVSS3: 6.5 | 0% Низкий | 3 месяца назад |
Уязвимостей на страницу